93 related articles for article (PubMed ID: 15010348)
1. Longitudinal progression of subclinical structural brain disease in normal aging.
Cook IA; Leuchter AF; Morgan ML; Dunkin JJ; Witte E; David S; Mickes L; O'Hara R; Simon S; Lufkin R; Abrams M; Rosenberg S
Am J Geriatr Psychiatry; 2004; 12(2):190-200. PubMed ID: 15010348
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects.
Cook IA; Leuchter AF; Morgan ML; Conlee EW; David S; Lufkin R; Babaie A; Dunkin JJ; O'Hara R; Simon S; Lightner A; Thomas S; Broumandi D; Badjatia N; Mickes L; Mody RK; Arora S; Zheng Z; Abrams M; Rosenberg-Thompson S
Arch Neurol; 2002 Oct; 59(10):1612-20. PubMed ID: 12374500
[TBL] [Abstract][Full Text] [Related]
3. Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study.
Cook IA; Morgan ML; Dunkin JJ; David S; Witte E; Lufkin R; Abrams M; Rosenberg S; Leuchter AF
Int J Geriatr Psychiatry; 2002 Jul; 17(7):610-8. PubMed ID: 12112157
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal MRI and cognitive change in healthy elderly.
Kramer JH; Mungas D; Reed BR; Wetzel ME; Burnett MM; Miller BL; Weiner MW; Chui HC
Neuropsychology; 2007 Jul; 21(4):412-8. PubMed ID: 17605574
[TBL] [Abstract][Full Text] [Related]
5. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population.
van den Heuvel DM; ten Dam VH; de Craen AJ; Admiraal-Behloul F; Olofsen H; Bollen EL; Jolles J; Murray HM; Blauw GJ; Westendorp RG; van Buchem MA
J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):149-53. PubMed ID: 16421114
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal volumetric MRI change and rate of cognitive decline.
Mungas D; Harvey D; Reed BR; Jagust WJ; DeCarli C; Beckett L; Mack WJ; Kramer JH; Weiner MW; Schuff N; Chui HC
Neurology; 2005 Aug; 65(4):565-71. PubMed ID: 16116117
[TBL] [Abstract][Full Text] [Related]
7. White matter lesions as a feature of cognitive impairment, low vitality and other symptoms of geriatric syndrome in the elderly.
Sonohara K; Kozaki K; Akishita M; Nagai K; Hasegawa H; Kuzuya M; Yokote K; Toba K
Geriatr Gerontol Int; 2008 Jun; 8(2):93-100. PubMed ID: 18713161
[TBL] [Abstract][Full Text] [Related]
8. Cortical thinning related to periventricular and deep white matter hyperintensities.
Seo SW; Lee JM; Im K; Park JS; Kim SH; Kim ST; Ahn HJ; Chin J; Cheong HK; Weiner MW; Na DL
Neurobiol Aging; 2012 Jul; 33(7):1156-67. PubMed ID: 21316813
[TBL] [Abstract][Full Text] [Related]
9. Clinical and neuroimaging correlates of mild cognitive impairment in a middle-aged community sample: the personality and total health through life 60+ study.
Kumar R; Parslow RA; Jorm AF; Rosenman SJ; Maller J; Meslin C; Anstey KJ; Christensen H; Sachdev PS
Dement Geriatr Cogn Disord; 2006; 21(1):44-50. PubMed ID: 16254430
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine, progression of ventricular enlargement, and cognitive decline: the Second Manifestations of ARTerial disease-Magnetic Resonance study.
Jochemsen HM; Kloppenborg RP; de Groot LC; Kampman E; Mali WP; van der Graaf Y; Geerlings MI;
Alzheimers Dement; 2013 May; 9(3):302-9. PubMed ID: 22863909
[TBL] [Abstract][Full Text] [Related]
11. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment.
Debette S; Bombois S; Bruandet A; Delbeuck X; Lepoittevin S; Delmaire C; Leys D; Pasquier F
Stroke; 2007 Nov; 38(11):2924-30. PubMed ID: 17885256
[TBL] [Abstract][Full Text] [Related]
12. Deep versus periventricular white matter lesions and cognitive function in a community sample of middle-aged participants.
Soriano-Raya JJ; Miralbell J; López-Cancio E; Bargalló N; Arenillas JF; Barrios M; Cáceres C; Toran P; Alzamora M; Dávalos A; Mataró M
J Int Neuropsychol Soc; 2012 Sep; 18(5):874-85. PubMed ID: 22687604
[TBL] [Abstract][Full Text] [Related]
13. Cerebral small-vessel disease and decline in information processing speed, executive function and memory.
Prins ND; van Dijk EJ; den Heijer T; Vermeer SE; Jolles J; Koudstaal PJ; Hofman A; Breteler MM
Brain; 2005 Sep; 128(Pt 9):2034-41. PubMed ID: 15947059
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors.
Chowdhury MH; Nagai A; Bokura H; Nakamura E; Kobayashi S; Yamaguchi S
J Stroke Cerebrovasc Dis; 2011; 20(4):302-9. PubMed ID: 20634092
[TBL] [Abstract][Full Text] [Related]
15. The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases.
Murray AD; Staff RT; McNeil CJ; Salarirad S; Ahearn TS; Mustafa N; Whalley LJ
Brain; 2011 Dec; 134(Pt 12):3687-96. PubMed ID: 22102649
[TBL] [Abstract][Full Text] [Related]
16. Progressive gray matter atrophy in lacunar patients with vascular mild cognitive impairment.
Grau-Olivares M; Arboix A; Junqué C; Arenaza-Urquijo EM; Rovira M; Bartrés-Faz D
Cerebrovasc Dis; 2010; 30(2):157-66. PubMed ID: 20551631
[TBL] [Abstract][Full Text] [Related]
17. Cortical gray matter atrophy in healthy aging cannot be explained by undetected incipient cognitive disorders: a comment on Burgmans et al. (2009).
Fjell AM; Westlye LT; Espeseth T; Reinvang I; Dale AM; Holland D; Walhovd KB
Neuropsychology; 2010 Mar; 24(2):258-63; discussion 264-266. PubMed ID: 20230119
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary function, cognitive impairment and brain atrophy in a middle-aged community sample.
Sachdev PS; Anstey KJ; Parslow RA; Wen W; Maller J; Kumar R; Christensen H; Jorm AF
Dement Geriatr Cogn Disord; 2006; 21(5-6):300-8. PubMed ID: 16484809
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of cortical gray matter atrophy may be overestimated in the healthy aging brain.
Burgmans S; van Boxtel MP; Vuurman EF; Smeets F; Gronenschild EH; Uylings HB; Jolles J
Neuropsychology; 2009 Sep; 23(5):541-50. PubMed ID: 19702408
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.
Ossenkoppele R; van der Flier WM; Verfaillie SC; Vrenken H; Versteeg A; van Schijndel RA; Sikkes SA; Twisk J; Adriaanse SM; Zwan MD; Boellaard R; Windhorst AD; Barkhof F; Scheltens P; Lammertsma AA; van Berckel BN
Neurology; 2014 May; 82(20):1768-75. PubMed ID: 24748672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
